uantoBio, located at Beijing Economic and Technological Development Area, Beijing, China, was founded by former employees from Invitrogen/Biosource and BD PharMingen and researchers at US universities in September 2009.
QuantoBio focuses on developing and manufacturing high quality reagents on the research on immunology, cell biology, cancer, inflammation and related diseases for the market in the World as well as China.
The product portfolios include immunoassays, recombinant bioactive proteins, antibodies on various applications including flow cytometry, Western blotting and Immunohistochemistry, microRNA profiling and assay kits and other cutting-edge research reagents. The vigorous product development combines internal product development, technology licensing, and collaborations with research laboratories worldwide.
With rich experience and knowledge in product development, we offer the ranges of custom services on immunoassay and antibody developments, recombinant protein expression and bioassays, microRNA profiling, microRNA overexpression and knock-down.
quantoBio has not received any reviews.
quantoBio has not received any endorsements.